Navigation Links
Medizone Expects OTCBB Listing
Date:8/5/2009

SAN FRANCISCO, Aug. 5 /PRNewswire-FirstCall/ -- Medizone International, Inc. (Pink Sheets: MZEI) announced that a market maker has filed the required documentation to list the company on the Over The Counter Bulletin Board (OTCBB). The company is currently listed as a full SEC reporting company on the Pink Sheets and expects to achieve a listing on the OTCBB before the end of August 2009.

Medizone will hold its annual meeting of shareholders on August 26, 2009 in Reno, Nevada. At the meeting, officials of the company will update shareholders on the company's business and shareholders will vote on matters presented by the proxy statement on file with the Securities and Exchange Commission and made available electronically to the company's shareholders. In addition to voting on the election of directors, for the first time since the company became a public company in 1986 the shareholders will vote to increase the number of shares the company is authorized to issue. As noted in the proxy statement, the company has historically relied on the sale of its common stock to finance its operations and research and development. A modest portion of the newly authorized shares would facilitate the financing of hospital beta testing and initial production of the company's AsepticSure hospital sterilization system. "Importantly," noted Edwin Marshall, CEO of the company, "the availability of increased authorized capital will also give management greater flexibility for strategic development and other transactions."

Marshall further clarified the business strategy, "Medizone is preparing a transition into the hospital beta testing stage. We now expect to begin hospital testing during October using production prototype equipment. We are targeting initial sales before the end of this year with deliveries during the first quarter of 2010 expected to bring the company to a break-even cash flow. Our initial production rates will be kept on the conservative side until the design proves very reliable in the field and a dramatic increase in production would not offer significant risk. At that point in time we will have optimized our strengths as a research and development company and expect to partner with a multinational corporation in the hospital sector for increased manufacturing capacity, sales and service. The target is to achieve profitability moving into mid-year 2010."

Medizone International, Inc., is a research and development company engaged in developing its AsepticSure(TM) technology to decontaminate and sterilize hospital surgical suites, emergency rooms, intensive care units, schools and other critical infrastructure. Current trials will now be expanded to include a hospital mock-up and then hospital beta testing of the production prototype. Initial sales are currently targeted to commence by the end of this year.

This Press Release contains certain forward looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company's filings made with the Securities and Exchange Commission.

    Investor Relations: 800-953-3350 / web site: www.medizoneint.com
    E-mail: operations @ medizoneint.com


'/>"/>
SOURCE Medizone International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Medizone International, Inc. Announces Strategic Consulting Relationship With TDV Global, Inc.
2. The Canadian Foundation for Global Health Announces a Research and Development Partnership with Medizone International, Inc.
3. Medizone Announces a Second Round of Trials Have Begun.
4. Medizone Announces That Its AsepticSure(TM) Development Program is Reaching Objectives on Two Fronts
5. Medizone International, Inc. (MZEI.PK) Announces it has Established its Own BSL2A Certified Laboratory Located in Innovation Park, Queens University at Kingston, Ontario, Canada.
6. Medizone International, Inc. Has Filed for Patent Protection for Its AsepticSure(TM) Hospital Sterilization System
7. ReBuilder Medical Technologies, Inc. Contracts with ETS to Manufacture the Newest Version of its ReBuilder Neuropathy Treatment Device; Expects Sales to Increase 30%
8. ATS Medical Expects Fourth Quarter Revenue to Increase by Approximately 32%
9. NightHawk Radiology Holdings, Inc. Announces Preliminary Results of Its Tender Offer; NightHawk Expects to Purchase 2,367,438 Shares of Its Common Stock at $8.05 per Share
10. Chubb Expects to Release Earnings on July 24 and Hold Conference Call on the Same Day
11. ATS Medical Expects Second Quarter Revenue of $16.7 to $16.9 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway ... call for a minimum wage raise to $12 an hour by 2020 and then adjusting ... restore the lost value of the minimum wage, assure the wage floor does not erode ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
(Date:6/23/2016)... PARK RIDGE, Ill. and INDIANAPOLIS ... caliber of students receiving a Lilly Diabetes Tomorrow,s Leaders ... hands. The 2016 scholarship winners, announced today online at ... refused to let type 1 diabetes stand in the ... Lilly Diabetes has supported the Foundation,s scholarship program since ...
(Date:6/23/2016)... -- The vast majority of dialysis patients currently receive ... usually 3 times a week, with treatment times averaging ... equipment preparation and wait time.  This regimen can be ... who are elderly and frail.  Many elderly dialysis patients ... for some duration of time. Residents in ...
Breaking Medicine Technology: